Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 3/2021

01-03-2021 | Obesity | Original Contributions

Barrett’s Oesophagus and Bariatric/Metabolic Surgery—IFSO 2020 Position Statement

Authors: Oliver M. Fisher, Daniel L. Chan, Michael L. Talbot, Almino Ramos, Ahmad Bashir, Miguel F. Herrera, Jacques Himpens, Scott Shikora, Kelvin D. Higa, Lilian Kow, Wendy A. Brown

Published in: Obesity Surgery | Issue 3/2021

Login to get access

Abstract

The International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) has been playing an integral role in educating both the metabolic surgical and the medical community at large about the importance of surgical and/or endoscopic interventions in treating adiposity-based chronic diseases. The occurrence of chronic conditions following bariatric/metabolic surgery (BMS), such as gastro-oesophageal reflux disease (GERD) and columnar (intestinal) epithelial metaplasia of the distal oesophagus (also known as Barrett’s oesophagus (BE)), has long been discussed in the metabolic surgical and medical community. Equally, the risk of neoplastic progression of Barrett’s oesophagus to oesophageal adenocarcinoma (EAC) and the resulting requirement for surgery are the source of some concern for many involved in the care of these patients, as the surgical alteration of the gastrointestinal tract may lead to impaired reconstructive options. As such, there is a requirement for guidance of the community.The IFSO commissioned a task force to elucidate three aspects of the presenting problem: First, to determine what the estimated incidence of Barrett’s oesophagus is in patients presenting for BMS; second, to determine the frequency at which Barrett’s oesophagus may develop following BMS (with a particular focus on the laparoscopic sleeve gastrectomy (LSG)); and third, to determine if regression of Barrett’s oesophagus may occur following BMS given the close relationship of obesity and the development of BE/EAC. Based on these findings, a position statement regarding the management of this pathology in the context of BMS was developed. The following position statement is issued by the IFSO Barrett’s Oesophagus task force andapproved by the IFSO Scientific Committee and Executive Board. This statement is based on current clinical knowledge, expert opinion and published peer-reviewed scientific evidence. It will be reviewed regularly.
Appendix
Available only for authorised users
Literature
1.
A. Ramos, W. Brown, R. Welbourn, J. Dixon, R. Kinsman, P. Walton, 5th IFSO Global Registry Report. 2019, IFSO p 46.
2.
Thrift AP et al. Obesity and risk of esophageal adenocarcinoma and Barrett’s esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014;106(11):dju252.CrossRef
3.
Kendall BJ, Thrift AP. Unravelling the riddle of gastroesophageal reflux disease, obesity, and Barrett’s esophagus. Clin Gastroenterol Hepatol. 2015;13(13):2273–5.CrossRef
4.
Spechler SJ, Souza RF. Barrett’s esophagus. N Engl J Med. 2014;371(9):836–45.CrossRef
5.
Peterli R, Borbély Y, Kern B, et al. Early results of the Swiss Multicentre Bypass or Sleeve Study (SM-BOSS): a prospective randomized trial comparing laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass. Ann Surg. 2013;258(5):690–4. discussion 695
6.
Salminen P, Helmiö M, Ovaska J, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA. 2018;319(3):241–54.
7.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
8.
9.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.CrossRef
10.
Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.
11.
Altman DG, Bland JM. Interaction revisited: the difference between two estimates. BMJ. 2003;326(7382):219.CrossRef
12.
Egger M, Smith GD, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
13.
Team, R.C. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2013.
14.
Alejandro Pantoja Aguirre, HK, Rivas H, Morton JM, Su2048: Prevalence of pre-operative endoscopic findings for sleeve gastrectomy patients. Gastroenterology, 2017: p. S-1260.
15.
16.
Andrew B, Alley JB, Aguilar CE, et al. Barrett’s esophagus before and after Roux-en-Y gastric bypass for severe obesity. Surg Endosc. 2018;32(2):930–6.
17.
Azagury D, Dumonceau JM, Morel P, et al. Preoperative work-up in asymptomatic patients undergoing Roux-en-Y gastric bypass: is endoscopy mandatory? Obes Surg. 2006;16(10):1304–11.
18.
Balsiger BM, Murr MM, Mai J, et al. Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass. J Gastrointest Surg. 2000;4(3):276–81.
19.
Aviv Ben-Meir IS, Salomone MG. P-62: Roux-en-Y gastric bypass (RYGB) improves Barrett’s esophagus. Surg Obes Relat Dis. 2010;6(3):S48–9.CrossRef
20.
Berry MA, Urrutia L, Lamoza P, et al. Sleeve gastrectomy outcomes in patients with BMI between 30 and 35-3 years of follow-up. Obes Surg. 2018;28(3):649–55.
21.
Braghetto I, Csendes A. Prevalence of Barrett’s esophagus in bariatric patients undergoing sleeve gastrectomy. Obes Surg. 2016;26(4):710–4.CrossRef
22.
Braghetto I, Korn O, Csendes A, et al. Laparoscopic treatment of obese patients with gastroesophageal reflux disease and Barrett’s esophagus: a prospective study. Obes Surg. 2012;22(5):764–72.
23.
Caravelli G, Di Pierro M, Morace F, Verde C, Amalfi G , P.12.13: Advantages of transnasal esophagogastroduodenoscopy in preoperative evaluation of patients undergoing bariatric surgery. Dig Liver Dis, 2017: p. e73–e223.
24.
25.
Chang VC, Pan P, Shah SK, et al. Routine preoperative endoscopy in patients undergoing bariatric surgery. Surg Obes Relat Dis. 2020;16:745–50.
26.
27.
Csendes A, Burgos AM, Smok G, et al. Endoscopic and histologic findings of the foregut in 426 patients with morbid obesity. Obes Surg. 2007;17(1):28–34.
28.
Csendes A et al. Effect of gastric bypass on Barrett’s esophagus and intestinal metaplasia of the cardia in patients with morbid obesity. J Gastrointest Surg. 2006;10(2):259–64.CrossRef
29.
D’Hondt M et al. Value of preoperative esophagogastroduodenoscopy in morbidly obese patients undergoing laparoscopic Roux-en-Y gastric bypass. Acta Chir Belg. 2013;113(4):249–53.CrossRef
30.
D’Silva M et al. High-percentage pathological findings in obese patients suggest that esophago-gastro-duodenoscopy should be made mandatory prior to bariatric surgery. Obes Surg. 2018;28(9):2753–9.CrossRef
31.
Dova G, Caro LE, Brasesco O, et al. Tu1141: effects of gastric bypass in obese patients with Barrett’s esophagus. Gastrointest Endosc. 2016;83:AB551.
32.
Endo Y, Ohta M, Tada K, et al. Clinical significance of upper gastrointestinal endoscopy before laparoscopic bariatric procedures in Japanese patients. Surg Today. 2019;49(1):27–31.
33.
Estevez-Fernandez S et al. Esophagogastric pathology in morbid obese patient: preoperative diagnosis, influence in the selection of surgical technique. Rev Esp Enferm Dig. 2015;107(7):408–12.PubMed
34.
Felsenreich DM, Ladinig LM, Beckerhinn P, et al. Update: 10 years of sleeve gastrectomy-the first 103 patients. Obes Surg. 2018;28(11):3586–94.
35.
Felsenreich DM, Langer FB, Bichler C, et al. Roux-en-Y gastric bypass as a treatment for Barrett’s esophagus after sleeve gastrectomy. Obes Surg. 2020;30(4):1273–9.
36.
Gomez V et al. Routine screening endoscopy before bariatric surgery: is it necessary? Bariatr Surg Pract Patient Care. 2014;9(4):143–9.CrossRef
37.
Gorodner V, Buxhoeveden R, Clemente G, et al. Barrett’s esophagus after Roux-en-Y gastric bypass: does regression occur? Surg Endosc. 2017;31(4):1849–54.
38.
Heimgartner B, Herzig M, Borbély Y, et al. Symptoms, endoscopic findings and reflux monitoring results in candidates for bariatric surgery. Dig Liver Dis. 2017;49(7):750–6.
39.
Houghton SG, Romero Y, Sarr MG. Effect of Roux-en-Y gastric bypass in obese patients with Barrett’s esophagus: attempts to eliminate duodenogastric reflux. Surg Obes Relat Dis. 2008;4(1):1–4. discussion 4-5CrossRef
40.
Humphreys LM, Meredith H, Morgan J, et al. Detection of asymptomatic adenocarcinoma at endoscopy prior to gastric banding justifies routine endoscopy. Obes Surg. 2012;22(4):594–6.
41.
Pauline Jouet JB, Coffin B, Msika S, et al. Results of routine endoscopy performed in patients with morbid obesity before bariatric surgery and prevalence of Helicobacter pylori: a single center study in 288 patients. Gastroenterology. 2011;140(5):S-563.
42.
Kazantsev G. M2073: preoperative endoscopy in patients undergoing Roux-en-Y gastric bypass for morbid obesity: is it necessary? Gastroenterology. 2005;128(4):A1–A821. (817)
43.
Kuper MA et al. Effort, safety, and findings of routine preoperative endoscopic evaluation of morbidly obese patients undergoing bariatric surgery. Surg Endosc. 2010;24(8):1996–2001.CrossRef
44.
Masci E, Viaggi P, Mangiavillano B, et al. No increase in prevalence of Barrett’s oesophagus in a surgical series of obese patients referred for laparoscopic gastric banding. Dig Liver Dis. 2011;43(8):613–5.
45.
Matar R, Maselli D, Vargas E, et al. Esophagitis after bariatric surgery: large cross-sectional assessment of an endoscopic database. Obes Surg. 2020;30(1):161–8.
46.
Mong C, van Dam J, Morton J, et al. Preoperative endoscopic screening for laparoscopic Roux-en-Y gastric bypass has a low yield for anatomic findings. Obes Surg. 2008;18(9):1067–73.
47.
Moulla Y, Lyros O, Mehdorn M, et al. Preoperative upper-GI endoscopy prior to bariatric surgery: essential or optional? Obes Surg. 2020;30(6):2076–84.
48.
Munoz R et al. Importance of routine preoperative upper GI endoscopy: why all patients should be evaluated? Obes Surg. 2009;19(4):427–31.CrossRef
49.
Naslund E et al. Six cases of Barrett’s esophagus after gastric restrictive surgery for massive obesity: an extended case report. Obes Surg. 1996;6(2):155–8.CrossRef
50.
Ozeki KA, Tran SA, Cheung R, et al. Preoperative endoscopic findings in veterans undergoing bariatric surgery: prevalence and predictors of Barrett’s esophagus. Obes Surg. 2020;30(2):657–63.
51.
Peromaa-Haavisto P, Victorzon M. Is routine preoperative upper GI endoscopy needed prior to gastric bypass? Obes Surg. 2013;23(6):736–9.CrossRef
52.
Rosenthal RJ et al. Laparoscopic surgery for morbid obesity: 1,001 consecutive bariatric operations performed at The Bariatric Institute, Cleveland Clinic Florida. Obes Surg. 2006;16(2):119–24.CrossRef
53.
Saarinen T, Kettunen U, Pietiläinen KH, et al. Is preoperative gastroscopy necessary before sleeve gastrectomy and Roux-en-Y gastric bypass? Surg Obes Relat Dis. 2018;14(6):757–62.
54.
Salama TMS, Hassan MI. Incidence of biliary reflux esophagitis after laparoscopic omega loop gastric bypass in morbidly obese patients. J Laparoendosc Adv Surg Tech A. 2017;27(6):618–22.CrossRef
55.
Mohannad Abou Saleh EM, Perry Y, Lee PJ, et al. Proportion of gastroesophageal reflux disease and Barrett’s esophagus in laparoscopic sleeve gastrectomy vs. Roux-en-Y gastrojejunostomy: a population based study. Gastroenterology. 2017;152(5):S453.
56.
Santo MA et al. Endoscopic changes related to gastroesophageal reflux disease: comparative study among bariatric surgery patients. Arq Bras Cir Dig. 2015;28(Suppl 1):36–8.CrossRef
57.
Schigt A, Coblijn U, Lagarde S, et al. Is esophagogastroduodenoscopy before Roux-en-Y gastric bypass or sleeve gastrectomy mandatory? Surg Obes Relat Dis. 2014;10(3):411–7. quiz 565-6
58.
Schirmer B, Erenoglu C, Miller A. Flexible endoscopy in the management of patients undergoing roux-en-Y gastric bypass. Obes Surg. 2002;12(5):634–8.CrossRef
59.
Schneider R, Lazaridis I, Kraljević M, et al. The impact of preoperative investigations on the management of bariatric patients; results of a cohort of more than 1200 cases. Surg Obes Relat Dis. 2018;14(5):693–9.
60.
Sebastianelli L, Benois M, Vanbiervliet G, et al. Systematic endoscopy 5 years after sleeve gastrectomy results in a high rate of Barrett’s esophagus: results of a multicenter study. Obes Surg. 2019;29(5):1462–9.
61.
Sharaf RN, Weinshel EH, Bini EJ, et al. Endoscopy plays an important preoperative role in bariatric surgery. Obes Surg. 2004;14(10):1367–72.
62.
Signorini F, Viscido G, Bocco MCA, et al. Impact of gastric bypass on erosive esophagitis and Barret’s esophagus. Obes Surg. 2020;30(4):1194–9.
63.
Sheppard CE, Sadowski DC, de Gara CJ, et al. Rates of reflux before and after laparoscopic sleeve gastrectomy for severe obesity. Obes Surg. 2015;25(5):763–8.
64.
Silva LE, Cruz Jr RJ, Alves MM, et al. P.260: simple, safe and effective. the omega loop gastric bypass added to “collis-nissen” like surgery (OLGBCN): 5-years outcomes of 512 cases from a single surgeon. Obes Surg. 2014;24:1136–378.
65.
Soricelli E, Casella G, Baglio G, et al. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018;14(6):751–6.
66.
Teivelis MP, Faintuch J, Ishida R, et al. Endoscopic and ultrasonographic evaluation before and after roux-en-Y gastric bypass for morbid obesity. Arq Gastroenterol. 2007;44(1):8–13.
67.
Velotti N, Bianco P, Russo T, et al. Evaluation of the gastroesophageal mucosa with endoscopic (EGD) computed virtual chromoendoscopy technologies (CVCT) in patients undergoing mini gastric bypass. gastric bypass procedures including Roux-en-y gastric bypass (RYGB) and one anastomosis gastric bypass (OAGB)/MGB. In: in International Federation for the Surgery of Obesity and Metabolic Disorders 22nd World Congress. London: IFSO; 2017. https://​link.​springer.​com/​content/​pdf/​10.​1007%2Fs11695-017-2774-7.​pdf. Accessed 01 Sep 2019.
68.
Wolter S, Duprée A, Miro J, et al. Upper gastrointestinal endoscopy prior to bariatric surgery-mandatory or expendable? An analysis of 801 cases. Obes Surg. 2017;27(8):1938–43.
69.
Zeni TM et al. Value of preoperative upper endoscopy in patients undergoing laparoscopic gastric bypass. Obes Surg. 2006;16(2):142–6.CrossRef
70.
Scherer RW, Saldanha IJ. How should systematic reviewers handle conference abstracts? A view from the trenches. Syst Rev. 2019;8(1):264.CrossRef
71.
Higgins JPT, Thomas J., Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane handbook for systematic reviews of interventions version 6.0 (updated July 2019). 2019 [cited 2020; 6.0: Available from: www.​training.​cochrane.​org/​handbook. Accessed 01 Sep 2019.
72.
Peterli R, Wölnerhanssen BK, Peters T, et al. Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA. 2018;319(3):255–65.
73.
Arman GA, Himpens J, Dhaenens J, et al. Long-term (11+years) outcomes in weight, patient satisfaction, comorbidities, and gastroesophageal reflux treatment after laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(10):1778–86.
74.
Felsenreich DM, Kefurt R, Schermann M, et al. Reflux, sleeve dilation, and Barrett’s esophagus after laparoscopic sleeve gastrectomy: long-term follow-up. Obes Surg. 2017;27(12):3092–101.
75.
Genco A, Soricelli E, Casella G, et al. Gastroesophageal reflux disease and Barrett’s esophagus after laparoscopic sleeve gastrectomy: a possible, underestimated long-term complication. Surg Obes Relat Dis. 2017;13(4):568–74.
76.
Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett’s esophagus in the general population: an endoscopic study. Gastroenterology. 2005;129(6):1825–31.
77.
Davis PA, Law S, Wong J. Colonic interposition after esophagectomy for cancer. Arch Surg. 2003;138(3):303–8.CrossRef
78.
El Khoury L et al. Esophageal adenocarcinoma in Barrett’s esophagus after sleeve gastrectomy: case report and literature review. Int J Surg Case Rep. 2018;52:132–6.CrossRef
79.
Schauer DP, Feigelson HS, Koebnick C, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.
80.
Mackenzie H, Markar SR, Askari A, et al. Obesity surgery and risk of cancer. Br J Surg. 2018;105(12):1650–7.
81.
Fisher O. M., L.R.V., Shackleford’s surgery of the alimentary tract. 8th Edition ed. Shackleford’s Surgery of the Alimentary Tract, ed. S.R.D. Charles J. Yeo, David W. McFadden, Jeffrey B. Matthews, James W. Fleshman. Vol. 1. 2019, Philadelphia: Elsevier.
82.
Contino G, Vaughan TL, Whiteman D, et al. The evolving genomic landscape of Barrett’s esophagus and esophageal adenocarcinoma. Gastroenterology. 2017;153(3):657–73. e1
83.
Raj PP, Bhattacharya S, Misra S, et al. Gastroesophageal reflux-related physiologic changes after sleeve gastrectomy and Roux-en-Y gastric bypass: a prospective comparative study. Surg Obes Relat Dis. 2019;15(8):1261–9.
84.
Anderson LA, Murray LJ, Murphy SJ, et al. Mortality in Barrett’s oesophagus: results from a population based study. Gut. 2003;52(8):1081–4.
85.
Solaymani-Dodaran M, Card TR, West J. Cause-specific mortality of people with Barrett’s esophagus compared with the general population: a population-based cohort study. Gastroenterology. 2013;144(7):1375–83. 1383 e1CrossRef
86.
Erichsen R, Horvath-Puho E, Lund JL, et al. Mortality and cardiovascular diseases risk in patients with Barrett’s oesophagus: a population-based nationwide cohort study. Aliment Pharmacol Ther. 2017;45(7):973–82.
87.
Cook MB, Coburn SB, Lam JR, et al. Cancer incidence and mortality risks in a large US Barrett’s oesophagus cohort. Gut. 2018;67(3):418–529.
88.
Jankowski JAZ, de Caestecker J, Love SB, et al. Esomeprazole and aspirin in Barrett’s oesophagus (AspECT): a randomised factorial trial. Lancet. 2018;392(10145):400–8.
89.
Bennett S, Gostimir M, Shorr R, et al. The role of routine preoperative upper endoscopy in bariatric surgery: a systematic review and meta-analysis. Surg Obes Relat Dis. 2016;12(5):1116–25.
90.
Brown WA, Johari Halim Shah Y, Balalis G, et al. IFSO position statement on the role of esophago-gastro-duodenal endoscopy prior to and after bariatric and metabolic surgery procedures. Obes Surg. 2020;30:3135–53.
91.
Vaughan TL, Fitzgerald RC. Precision prevention of oesophageal adenocarcinoma. Nat Rev Gastroenterol Hepatol. 2015;12(4):243–8.CrossRef
92.
Inadomi JM, Saxena N. Screening and surveillance for Barrett’s esophagus: is it cost-effective? Dig Dis Sci. 2018;63(8):2094–104.CrossRef
Metadata
Title
Barrett’s Oesophagus and Bariatric/Metabolic Surgery—IFSO 2020 Position Statement
Authors
Oliver M. Fisher
Daniel L. Chan
Michael L. Talbot
Almino Ramos
Ahmad Bashir
Miguel F. Herrera
Jacques Himpens
Scott Shikora
Kelvin D. Higa
Lilian Kow
Wendy A. Brown
Publication date
01-03-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 3/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05143-6

Other articles of this Issue 3/2021

Obesity Surgery 3/2021 Go to the issue

Letter to the Editor

Biliopancreatic Limb Lengths Affects Weight Loss in Roux-en-Y Gastric Bypass: Are We Close to the Truth?

Original Contributions

Gastric Fistula After Sleeve Gastrectomy: Clinical Features and Treatment Options

Original Contributions

K-Wire Retractor, a Trocar-Free Liver Retraction Technique in Bariatric Surgery

Original Contributions

Weight Loss as the First-Line Therapy in Patients with Severe Obesity and Obstructive Sleep Apnea Syndrome: the Role of Laparoscopic Sleeve Gastrectomy

Original Contributions

Efficacy and Safety of 100 Laparoscopy-Assisted Transgastric Endoscopic Retrograde Cholangiopancreatography Procedures in Patients with Roux-en-Y Gastric Bypass

Original Contributions

Weight Loss After Sleeve Gastrectomy: Does Type 2 Diabetes Status Impact Weight and Body Composition Trajectories?